Article
Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 May 2013
Zhou J X, Yang H, Deng Q, Gu X, He P, Lin Y, Zhao M, Jiang J, Chen H, Lin Y, Yin W, Mo L, He J
Abstract excerpt
BACKGROUND: Oncogenic driver mutations are responsible for the initiation and maintenance of non-small-cell lung cancer (NSCLC). Elucidation of driver mutation occurrence in NSCLC has important clinical implications. PATIENTS AND METHODS: NSCLC at various clinical stages were studied for their oncogenic mutations and their association with patients' disease-free survival (DFS). RESULTS: Of 488 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.